Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now presents the ClinicalTrials.gov record for a completed phase II pembrolizumab study in older adults with advanced lung cancer, including study methods, eligibility criteria, locations, and outcome measures. It also provides record history, study documents, and links to related resources.
    Difference
    49%
    Check dated 2026-11-08T23:24:08.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to show a 403 Forbidden error instead of the study record. The footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T23:26:44.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH website transition and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T22:45:13.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T23:08:51.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:12:29.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, removing the study details, locations, and related information from view. This indicates an access restriction rather than a substantive update to the page content.
    Difference
    18%
    Check dated 2026-09-20T22:30:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.